Risk factors for cancer and the importance of screening in adult recipients of living-donor kidney transplant
IS medication level was not a significant risk factor for cancer before graft failure. Nevertheless, cancer risk after KT significantly increased both DWFG and recipient mortality rates. Cancer screening may help reduce the incidence of DWFG and recipient mortality associated with cancer.
Authors
- Takahisa Hiramitsu (ORCID: https://orcid.org/0000-0003-1600-640X)
- Yuki Shimamoto
- Norihiko Goto (ORCID: https://orcid.org/0000-0003-4931-3203)
- Yuki Hasegawa
- Manabu Okada (ORCID: https://orcid.org/0000-0002-8446-7841)
- Toshihiro Ichimori
- Shunji Narumi (ORCID: https://orcid.org/0000-0003-1620-6962)
- Kenta Futamura
- Tomoki Himeno
- Takaaki Kobayashi
- Yutaka Matsuoka
- Yoshihiko Watarai
- Kazuharu Uchida
Institutions
- Aichi Medical University (JP)
- Nagoya Memorial Hospital (JP)
- Japanese Red Cross Nagoya Daini Hospital (JP)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-09
- DOI
- https://doi.org/10.3389/fimmu.2025.1678309
- Citations
- 1
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 24.20